Delve Bio Launches to Commercialize its Metagenomic Sequencing Platform for Infectious Disease Diagnosis

SAN FRANCISCO–(BUSINESS WIRE)– #NGS–Delve Bio emerges from stealth to commercialize its metagenomic sequencing platform for unbiased, hypothesis-free infectious disease diagnosis
Click here to view original post